Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance - the Chennai Urban Rural Epidemiology Study (CURES)

被引:78
作者
Deepa, Raj
Vehnurugan, Kaliyaperumal
Arvind, Kannan
Sivaram, Pillarisetti
Sientay, Cahoon
Uday, Saxena
Mohan, Viswanathan [1 ]
机构
[1] Madras Diabet Res Fdn, Madras 600086, Tamil Nadu, India
[2] Dr Mohans Diabet Specialities Ctr, Madras 600086, Tamil Nadu, India
[3] Reddy US Therapeut, Norcross, GA USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2006年 / 55卷 / 09期
关键词
D O I
10.1016/j.metabol.2006.05.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this cross-sectional study was to assess the association of insulin resistance (IR) with inflammatory molecules C-reactive protein (CRP), interleukin 6 (IL-6), vascular cell adhesion molecule I (VCAM-1), and monocyte chemotactic protein I (MCP-1) in urban South Indian subjects. The following groups were selected from the population-based Chennai Urban Rural Epidemiology Study: group I composed of 50 healthy subjects with normal glucose tolerance without IR; group 2 consisted of 50 normal glucose-tolerant subjects with IR as defined by homeostasis model assessment of IR (HOMA-IR); group 3 consisted of 50 subjects with impaired glucose tolerance (IGT); and groups 4 and 5 each comprised 50 newly diagnosed and known type 2 diabetic subjects, respectively. The inclusion criteria included nonsmokers; normal resting 12-lead electrocardiogram; and absence of angina, myocardial infarction, or history of any known vascular, infectious, or inflammatory diseases, and not on statins or aspirin. Normal glucose tolerance without IR had the lowest values of CRP, IL-6, and VCAM-I (CRP, 1.32 mg/L; IL-6, 12.56 pg/mL; VCAM-1, 277 pg/mL) followed by normal glucose tolerance with IR (CRP, 2.25 mg/L; IL-6,20.97 pg/mL; VCAM-1, 289 pg/mL), impaired glucose tolerance (CRP, 2.37 mg/L; IL-6,22.11 pg/mL; VCAM-1, 335 pg/mL), newly diagnosed diabetic subjects (CRP, 3.24 mg/L; IL-6, 23.21 pg/mL; VCAM-1, 568 pg/mL), and the highest levels were in the known diabetic subjects (CRP, 4.08 mg/L; IL-6, 29.44 pg/mL; VCAM-1, 577 pg/mL). This trend was statistically significant (P <.001). However, monocyte chemotactic protein I did not show such a trend and did not differ significantly between groups. In nondiabetic subjects, Pearson correlation analysis revealed that CRP (r = 0.299; P <.00 1) and IL-6 (r = 0. 180, P =.025) had a significant correlation with HOMA-IR. Monocyte chennotactic protein I did not show any correlation with HOMA-IR. Multiple linear regression analysis revealed CRP to be significantly associated with HOMA-IR (beta =.229; P <.00 1) and this was unaltered by the addition of waist and IL-6 into the model (beta =.158; P =.028). In conclusion, this study shows that in Asian Indians, inflammatory markers (CRP, IL-6, and VCAM-1) increase with increasing degrees of glucose intolerance. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1232 / 1238
页数:7
相关论文
共 39 条
[1]   Ethnicity and type 2 diabetes - Focus on Asian Indians [J].
Abate, N ;
Chandalia, M .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2001, 15 (06) :320-327
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]   Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism [J].
Blüher, M ;
Fasshauer, M ;
Tönjes, A ;
Kratzsch, J ;
Schön, MR ;
Paschke, R .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (09) :534-537
[5]   Comparison of serum concentrations of C-reactive protein, TNF-α, and interleukin 6 between elderly Korean women with normal and impaired glucose tolerance [J].
Choi, KM ;
Lee, J ;
Lee, KW ;
Seo, JA ;
Oh, JH ;
Kim, SG ;
Kim, NH ;
Choi, DS ;
Baik, SH .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 64 (02) :99-106
[6]   Metabolic syndrome - A comprehensive perspective based on interactions between obesity, diabetes, and inflammation [J].
Dandona, P ;
Aljada, A ;
Chaudhuri, A ;
Mohanty, P ;
Garg, R .
CIRCULATION, 2005, 111 (11) :1448-1454
[7]   C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J].
Danesh, J ;
Wheeler, JG ;
Hirschfield, GM ;
Eda, S ;
Eiriksdottir, G ;
Rumley, A ;
Lowe, GDO ;
Pepys, MB ;
Gudnason, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1387-1397
[8]  
Deepa M, 2003, J Assoc Physicians India, V51, P863
[9]  
Deepa R, 2002, INDIAN J MED RES, V115, P118
[10]   Low-grade systemic inflammation and the development of type 2 diabetes - The atherosclerosis risk in communities study [J].
Duncan, BB ;
Schmidt, MI ;
Pankow, JS ;
Ballantyne, CM ;
Couper, D ;
Vigo, A ;
Hoogeveen, R ;
Folsom, AR ;
Heiss, G .
DIABETES, 2003, 52 (07) :1799-1805